ConsenSys CEO: Ethereum spot ETF may trigger a "demand surge", leading to ETH supply shortage
According to DL News, Ethereum co-founder and CEO of crypto infrastructure company ConsenSys, Joe Lubin, stated that if an Ethereum spot ETF is approved, the resulting "demand surge" for Ethereum could lead to supply constraints.
Lubin explained that institutions already exposed to Bitcoin through the newly launched Bitcoin ETF are "most likely to want to diversify their investments into the second approved ETF". The demand for purchasing Ethereum through an ETF will be quite large. However, compared with when the Bitcoin spot ETF was approved in January this year, there will be less supply available to meet this demand.
In the case of Bitcoin, authorized participants (i.e., companies that buy Bitcoin on behalf of the ETF every day) can simply purchase idle Bitcoins on exchanges or from over-the-counter trading counterparts. But on-chain data shows that more than 27% of total Ethereum supply has been staked on the Ethereum network. These Ether coins are locked in contracts earning returns for their owners. In other words, not only is Ethereum's market value lower than Bitcoin's - making its price more sensitive to capital inflows - but a significant portion of its supply cannot be used by an ETF. Furthermore, new activities on Ethereum will result in a large amount of existing Ether being destroyed over time further limiting supply.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
